col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


27 Ergebisse       Seite 1

 [1] 
Elsevier: Clinics in Laboratory Medicine
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Dez―20 A Meta-analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Anti-spike Immunoglobulin G Antibody Durability up to 9 Months After Full Vaccination in Adults Maura C. Dodge, Christina Ellervik, Yachana Kataria
2 [GO] 2022―Nov―08 Review of SARS-CoV-2 Antigen and Antibody Testing in Diagnosis and Community Surveillance Robert D. Nerenz, Jacqueline A. Hubbard, Mark A. Cervinski
3 [GO] 2022―Mai―27 Covid-19 Molecular Testing and Clinical Correlates Sanjat Kanjilal, Yi-Wei Tang
4 [GO] 2022―Apr―06 A Tale of Trial and Triumph: Molecular Diagnostics for Severe Acute Respiratory Coronavirus 2 Over the First Two Years of the Coronavirus Disease 2019 Pandemic Sanjat Kanjilal, Yi-Wei Tang
5 [GO] 2022―Mrz―09 Novel assays for molecular detection of SARS-CoV-2 Kyle G. Rodino, Kenneth P. Smith, Matthew A. Pettengill
6 [GO] 2022―Mrz―08 An Overview of SARS-CoV-2 Molecular Diagnostics in Europe Emma Davies, Hamzah Z. Farooq, Benjamin Brown, Peter Tilston, Ashley McEwan, Andrew Birtles, et al. (+5)
7 [GO] 2022―Mrz―08 Strategies for Scaling Up SARS-CoV-2 Molecular Testing Capacity Sanchita Das, Karen M. Frank
8 [GO] 2022―Mrz―08 The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States Jennifer Dien Bard, N Esther Babady
9 [GO] 2022―Mrz―04 Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2 Nicole V. Tolan, Gary L. Horowitz
10 [GO] 2022―Mrz―04 SARS-CoV-2 molecular diagnostics in China Yanjun Lu, Ziyong Sun
11 [GO] 2022―Mrz―04 Rapid antigen assays for SARS-CoV-2: Promise and peril Thao T. Truong, Jennifer Dien Bard, Susan M. Butler-Wu
12 [GO] 2022―Mrz―01 Approaches to deployment of molecular testing for SARS-CoV-2 in resource-limited settings Gama Bandawe, Moses Chitenje, Joseph Bitiliyu Bangoh, Elizabeth Kampira
13 [GO] 2022―Feb―22 Performance of Non-Nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-2 Benjamin Kukull, Salika M. Shakir, Kimberly E. Hanson
14 [GO] 2022―Feb―21 Cycle threshold values from SARS-CoV-2 PCR assays: Interpretation and potential use cases Alexander J. McAdam
15 [GO] 2022―Feb―21 Analytic and clinical performance of major commercial SARS-CoV-2 molecular assays in the United States Michelle R. Campbell, Matthew J. Binnicker
16 [GO] 2022―Feb―10 Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19 Daimon P. Simmons, Peter H. Schur
17 [GO] 2021―Dez―21 Preface: Perspectives on Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 and Its Implications for Diagnostics, Biology, and Clinical Management Daimon P. Simmons, Peter H. Schur
18 [GO] 2021―Nov―03 Antibody dynamics and durability in COVID-19 Adam Zuiani, Duane R. Wesemann
19 [GO] 2021―Nov―03 Performance evaluation of lateral flow assays for COVID-19 serology Lucy Ochola, Paul Ogongo, Samuel Mungai, Jesse Gitaka, Sara Suliman
20 [GO] 2021―Nov―03 Coronavirus antigens as targets of antibody responses Alana F. Ogata, Roey Lazarovits, Augusta Uwamanzu-Nna, Tal Gilboa, Chi-An Cheng, David R. Walt
21 [GO] 2021―Nov―03 Alternative methods to detect SARS-CoV-2 antibodies Rashmi Patel, Siddharth Khare, Vinay S. Mahajan
22 [GO] 2021―Nov―03 Vaccine-induced SARS-CoV-2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection) Amy C. Sherman, Michael Desjardins, Lindsey R. Baden
23 [GO] 2021―Nov―03 SARS-CoV-2 Serology Testing - A Laboratory Primer Patricia R. Slev
24 [GO] 2021―Nov―03 Performance Characteristics of High-Throughput Serologic Assays for SARS-CoV-2 with FDA Emergency Use Authorization: A Review Elitza S. Theel
25 [GO] 2020―Aug―08 Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic Andy Ngo, Debra Masel, Christine Cahill, Neil Blumberg, Majed Refaai
26 [GO] 2020―Aug―08 Coronavirus Detection in the Clinical Microbiology Laboratory: Are We Ready for Identifying and Diagnosing a Novel Virus? Katharine Uhteg, Karen C. Carroll, Heba H. Mostafa
27 [GO] 2020―Aug―08 Measuring the Serological Response to SARS-CoV-2: Methods and Meaning Nicole D. Pecora, Martin S. Zand
 [1] 

27 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec